148 related articles for article (PubMed ID: 31768188)
1. Increased expression of protease-activated receptors 2 indicates poor prognosis in HBV related hepatocellular carcinoma.
Chen P; Yang N; Xu L; Zhao F; Zhang M
Infect Agent Cancer; 2019; 14():39. PubMed ID: 31768188
[TBL] [Abstract][Full Text] [Related]
2. The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy.
Tsai MC; Lin CC; Chen DW; Liu YW; Wu YJ; Yen YH; Huang PY; Yao CC; Chuang CH; Hsiao CC
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34199695
[No Abstract] [Full Text] [Related]
3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
5. Increased expression of osteopontin indicates poor prognosis in hepatocellular carcinoma.
Wang H; Guo D; Li J; Wei B; Zheng H
Int J Clin Exp Pathol; 2018; 11(12):5916-5922. PubMed ID: 31949679
[TBL] [Abstract][Full Text] [Related]
6. [The expression and significance of protease activated receptor 2 in ovarian epithelial carcinoma].
Liu SH; Ma YM; Zhang YN; Zhao XH; Wang HY; Li B
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):64-73. PubMed ID: 36709122
[No Abstract] [Full Text] [Related]
7. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
8. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Sun L; Li PB; Yao YF; Xiu AY; Peng Z; Bai YH; Gao YJ
World J Gastroenterol; 2018 Mar; 24(10):1120-1133. PubMed ID: 29563756
[TBL] [Abstract][Full Text] [Related]
9. Mitofusin-2 acts as biomarker for predicting poor prognosis in hepatitis B virus related hepatocellular carcinoma.
Wang X; Liu Y; Sun J; Gong W; Sun P; Kong X; Yang M; Zhang W
Infect Agent Cancer; 2018; 13():36. PubMed ID: 30498519
[TBL] [Abstract][Full Text] [Related]
10. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
[TBL] [Abstract][Full Text] [Related]
11. The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma.
Pan JJ; Ge YS; Xu GL; Jia WD; Liu WF; Li JS; Liu WB
J Cancer Res Clin Oncol; 2013 Jun; 139(6):1043-54. PubMed ID: 23525579
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression levels of ELOVL6 indicate poor prognosis in hepatocellular carcinoma.
Li H; Wang X; Tang J; Zhao H; Duan M
Oncol Lett; 2019 Dec; 18(6):6214-6220. PubMed ID: 31788097
[TBL] [Abstract][Full Text] [Related]
13. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Long Noncoding RNA SEMA6A-AS1 Expression with Clinical Outcome in HBV-Related Hepatocellular Carcinoma.
Yu S; Li N; Wang J; Fu Y; Huang Y; Yi P; Chen R; Tang D; Hu X; Fan X
Clin Ther; 2020 Mar; 42(3):439-447. PubMed ID: 32070484
[TBL] [Abstract][Full Text] [Related]
15. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of PED/PEA-15 at Ser116 and phosphorylation of p27 at Thr187 indicates a poor prognosis in hepatocellular carcinoma.
Wu Y; Li X; Chen M; Liu Z; Zhang X; Zheng S; Xu X
Oncol Lett; 2021 Mar; 21(3):177. PubMed ID: 33574916
[TBL] [Abstract][Full Text] [Related]
18. High expression of
Cai H; Zhu X; Qian F; Shao B; Zhou Y; Zhang Y; Chen Z
Transl Cancer Res; 2020 Feb; 9(2):983-992. PubMed ID: 35117443
[TBL] [Abstract][Full Text] [Related]
19. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
Tian F; Cai D
Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.
Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G
Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
